QI
EBS icon

QS Investors’s Emergent Biosolutions EBS Stock Holding History

QS Investors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$511K Hold
8,100
– – 0.01% 729
2021
Q1 		$753K Buy
8,100
+1,200
+17% +$123K 0.01% 613
2020
Q4 		$618K Hold
6,900
– – 0.01% 683
2020
Q3 		$713K Sell
6,900
-60,987
-90% -$6.57M 0.01% 563
2020
Q2 		$5.37M Sell
67,887
-1,400
-2% -$104K 0.07% 204
2020
Q1 		$4.01M Sell
69,287
-4,600
-6% -$265K 0.06% 241
2019
Q4 		$3.99M Sell
73,887
-1,280
-2% -$69.4K 0.04% 348
2019
Q3 		$3.93M Hold
75,167
– – 0.04% 341
2019
Q2 		$3.63M Sell
75,167
-1,260
-2% -$60.4K 0.04% 370
2019
Q1 		$3.86M Sell
76,427
-27,284
-26% -$1.61M 0.04% 349
2018
Q4 		$6.15M Hold
103,711
– – 0.08% 171
2018
Q3 		$6.83M Hold
103,711
– – 0.07% 191
2018
Q2 		$5.24M Buy
103,711
+2,207
+2% +$115K 0.05% 271
2018
Q1 		$5.34M Sell
101,504
-5,636
-5% -$281K 0.05% 240
2017
Q4 		$4.98M Sell
107,140
-2,852
-3% -$120K 0.05% 300
2017
Q3 		$4.45M Sell
109,992
-1,172
-1% -$42.4K 0.04% 350
2017
Q2 		$3.77M Sell
111,164
-728
-0.7% -$22.5K 0.03% 401
2017
Q1 		$3.25M Hold
111,892
– – 0.03% 451
2016
Q4 		$3.67M Sell
111,892
-24,951
-18% -$748K 0.03% 432
2016
Q3 		$4.32M Hold
136,843
– – 0.03% 422
2016
Q2 		$3.85M Sell
136,843
-32,800
-19% -$1.29M 0.03% 470
2016
Q1 		$6.17M Buy
169,643
+35,091
+26% +$1.24M 0.06% 321
2015
Q4 		$5.38M Buy
134,552
+67,752
+101% +$2.36M 0.05% 367
2015
Q3 		$1.9M Buy
+66,800
New +$2.2M 0.02% 632

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QS Investors's EBS Position: Q2 2021 in Review

QS Investors held its Emergent Biosolutions (EBS) position steady in Q2 2021 at 8,100 shares worth $511K. The position accounts for 0.01% of the portfolio, ranked #729.

QS Investors first reported a position in EBS in Q3 2015 and has held it in 24 quarters since. The position peaked at $6.83M in Q3 2018. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • QS Investors held 8,100 shares of Emergent Biosolutions worth $511K as of Q2 2021.
  • QS Investors left its Emergent Biosolutions share count unchanged in Q2 2021.
  • Emergent Biosolutions made up 0.01% of QS Investors's portfolio in Q2 2021, its #729 holding.
  • QS Investors first reported a position in Emergent Biosolutions in Q3 2015 and has held it in 24 quarters since.
  • QS Investors's Emergent Biosolutions position peaked at $6.83M in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.